Prasugrel - prasuvas - cipla is a platelet inhibitor drug , beneficial for acute coronary syndromes ( cad ) ,planned for percutaneous coronary intervention (pci). & reduces thrombotic events. , prasugrel inhibits adenosine diphosphate–induced platelet aggregation more rapidly, more consistently, and to a greater extent in its own category